Early research (Phase 1)Study completedNCT00767598
What this trial is testing
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
Who this might be right for
Pharmacokinetics of Three PDE5IsHealthy SubjectsGenetic Polymorphic CYP3A5
Inje University 21